[The localization of corticosteroid receptors in the dopaminergic structures of the canine brain]. 1993

V V Rakitskaia, and V G Shaliapina, and I A Garina, and N L Voĭlokova

Dopaminergic structures of the dog brain were found to be able to specifically bind corticosteroid hormones. The data obtained suggest localisation of corticosteroid receptors on the terminals of dopaminergic receptors.

UI MeSH Term Description Entries
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D011965 Receptors, Glucocorticoid Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example. Corticoid Type II Receptor,Glucocorticoid Receptors,Glucocorticoids Receptor,Corticoid II Receptor,Corticoid Type II Receptors,Glucocorticoid Receptor,Receptors, Corticoid II,Receptors, Corticoid Type II,Receptors, Glucocorticoids,Corticoid II Receptors,Glucocorticoids Receptors,Receptor, Corticoid II,Receptor, Glucocorticoid,Receptor, Glucocorticoids
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016627 Oxidopamine A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals. 6-Hydroxydopamine,6-OHDA,Oxidopamine Hydrobromide,Oxidopamine Hydrochloride,6 Hydroxydopamine,Hydrobromide, Oxidopamine,Hydrochloride, Oxidopamine

Related Publications

V V Rakitskaia, and V G Shaliapina, and I A Garina, and N L Voĭlokova
January 1992, Progress in histochemistry and cytochemistry,
V V Rakitskaia, and V G Shaliapina, and I A Garina, and N L Voĭlokova
January 1984, Ceskoslovenska fysiologie,
V V Rakitskaia, and V G Shaliapina, and I A Garina, and N L Voĭlokova
December 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
V V Rakitskaia, and V G Shaliapina, and I A Garina, and N L Voĭlokova
August 1993, Cellular and molecular neurobiology,
V V Rakitskaia, and V G Shaliapina, and I A Garina, and N L Voĭlokova
January 1984, Life sciences,
V V Rakitskaia, and V G Shaliapina, and I A Garina, and N L Voĭlokova
January 1984, Clinical and experimental hypertension. Part A, Theory and practice,
V V Rakitskaia, and V G Shaliapina, and I A Garina, and N L Voĭlokova
October 1997, The International journal of neuroscience,
V V Rakitskaia, and V G Shaliapina, and I A Garina, and N L Voĭlokova
October 1978, British journal of pharmacology,
V V Rakitskaia, and V G Shaliapina, and I A Garina, and N L Voĭlokova
January 2002, Brain research bulletin,
V V Rakitskaia, and V G Shaliapina, and I A Garina, and N L Voĭlokova
August 2021, Pharmacological research,
Copied contents to your clipboard!